IPO 2024 Special 301 Review Comments
IPO 2024 Special 301 Review Comments
IPO 2024 Special 301 Review Comments
IPO's Notice of Intent to Testify and Hearing Statement re: [...]
IPO's Comments to Department of Health and Human Services Re: [...]
IPO Comments to USPTO on WIPO IGC Negotiations on Genetic [...]
2023 Top 300 Patent Owners
RESOLVED, that IPO supports the USPTO’s transition to DOCX filing [...]
IPO Amicus Brief in In Re Cellect, 22-1293
IPO Comments to the U.S. Copyright Office re: Artificial Intelligence [...]
IPO Amicus Brief in LKQ Corp. v. GM Global Technology [...]
Resolved, that IPO opposes the Affordable Prescriptions for Patients Act [...]